Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2003/003933external-prioritypatent/WO2004026306A2/en
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Publication of TNSN05082A1publicationCriticalpatent/TNSN05082A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Des dérivés de pyrazole nouveaux de formule (Ia), Des intermédiaires pour leur préparation, des compositions pharmaceutiques les contenant et leur utilisation en médecine sont décrits. Les composés de la présente invention sont de puissants inhibiteurs de la voie de transmission de signal du facteur de croissance transformant ("TGF")- beta . Ils sont utiles dans le traitement de divers états pathologiques en rapport avec le TGF, comprenant, par exemple, le cancer et des maladies fibrotiques.Novel pyrazole derivatives of formula (Ia), intermediates for their preparation, pharmaceutical compositions containing them and their use in medicine are described. The compounds of the present invention are potent inhibitors of the transforming growth factor ("TGF") - beta signaling pathway. They are useful in the treatment of various disease states related to TGF, including, for example, cancer and fibrotic diseases.
TNP2005000082A2002-09-182005-03-18
PYRAZOLE DERIVATIVES AS INHIBITORS OF TRANSFORMING GROWTH FACTOR (TGF)
TNSN05082A1
(en)